Federal Contractor Profile
Leidos Biomedical Research INC
$8.82B obligated·255 awards·1 agencies·3 NAICS
Federal Contracts
Showing contracts 1–50 of 747 total. Sorted by action date, most recent first. Excludes $0 modifications.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Apr 21, 2026 | Department of Health and Human ServicesNIH NCI | 75N91026F00009 | 541715 | FY26 126771 - B1022 AUTOCLAVE REPLACEMENT | $1.7M |
| Apr 20, 2026 | Department of Health and Human ServicesNIH NCI | 75N91026F00005 | 541715 | FY26 126776 - B567 REPLACE TUNNEL WASHER | $901K |
| Apr 14, 2026 | Department of Health and Human ServicesNIH NCI | 75N91026F00007 | 541715 | 126826 - B1040 UPGRADE CHILLER #2 | $478K |
| Apr 14, 2026 | Department of Health and Human ServicesNIH NCI | 75N91026F00010 | 541715 | FY26 TO 10 - B539 CHILLED WATER PUMPS BACKUP POWER | $601K |
| Apr 13, 2026 | Department of Health and Human ServicesNIH NCI | 75N91026F00004 | 541715 | FY26 126746 - B560 EMERGENCY GENERATOR | $869K |
| Apr 9, 2026 | Department of Health and Human ServicesNIH NCI | 75N91020F00021 | 541715 | CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM | $11.2M |
| Mar 27, 2026 | Department of Health and Human ServicesNIH NCI | 75N91024F00031 | 541715 | FY24 FACILITIES TO J ATRF BDP FACILITY IMPROVEMENTS | $23K |
| Mar 12, 2026 | Department of Health and Human ServicesNIH NCI | 75N91023F00005 | 541715 | FY23 FACILITIES TO-A | $70K |
| Feb 6, 2026 | Department of Health and Human ServicesNIH NCI | 75N91025F00016 | 541715 | NCI OPERATIONAL TASK ORDER, FY26-FY27 | $221K |
| Jan 29, 2026 | Department of Health and Human ServicesNIH NCI | 75N91021F00004 | 541715 | ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2) | $102.8M |
| Jan 7, 2026 | Department of Health and Human ServicesNIH NCI | 75N91019F00134 | 541715 | FFRDC MOONSHOT PORTFOLIO TASK ORDER | $300K |
| Dec 16, 2025 | Department of Health and Human ServicesNIH NCI | 75N91021F00013 | 541715 | ENABLING NCI CLINICAL & RESEARCH DATA SHARING | $16.1M |
| Sep 30, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00008 | 541715 | FY25 TO-C REFURBISH ELEVATORS | $4.3M |
| Sep 29, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00016 | 541715 | NCI OPERATIONAL TASK ORDER, FY26-FY27 | $271.0M |
| Sep 29, 2025 | Department of Health and Human ServicesNIH NCI | 75N91020F00021 | 541715 | CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM | $3.2M |
| Sep 29, 2025 | Department of Health and Human ServicesNIH NCI | 75N91020F00009 | 541715 | ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19 (2,000 SUBJECTS | $5.9M |
| Sep 29, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00017 | 541715 | CHARACTERIZATION OF MPOX | $5.6M |
| Sep 29, 2025 | Department of Health and Human ServicesNIH NCI | 75N91019F00139 | 541715 | MD NET | $41.9M |
| Sep 25, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00012 | 541715 | NIAID DCR FY26-27 OPERATIONAL TASK ORDER | $57.1M |
| Sep 25, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00014 | 541715 | NIAID VRC FY26-27 OPERATIONAL TASK ORDER | $36.6M |
| Sep 25, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00013 | 541715 | THE NIAID DIR FY26-27 OPERATIONAL TASK ORDER | $7.5M |
| Sep 25, 2025 | Department of Health and Human ServicesNIH NCI | 75N91020F00026 | 541715 | DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS | $17.5M |
| Sep 25, 2025 | Department of Health and Human ServicesNIH NCI | HHSN26100023 | 561210 | IGF::OT::IGF BLDG. 538- 1ST FLOOR REFURBISHMENT AND INFRASTRUCTURE | $745K |
| Sep 25, 2025 | Department of Health and Human ServicesNIH NCI | 75N91023F00005 | 541715 | FY23 FACILITIES TO-A | $149K |
| Sep 24, 2025 | Department of Health and Human ServicesNIH NCI | 75N91020F00025 | 541715 | DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS OF A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT AND PEDIATRIC PATIENTS WITH UNKNOWN FEBRILE ILLNESS FR | $8.3M |
| Sep 24, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00026 | 541715 | FY25 TO-H W3F1 RENOVATIONS | $1.9M |
| Sep 22, 2025 | Department of Health and Human ServicesNIH NCI | 75N91023F00017 | 541715 | THE NIAID MISSION AND SCOPE INCLUDING RESEARCH AND DEVELOPMENT OF VACCINES AND THERAPEUTICS FOR THE PREVENTION AND TREATMENT OF DISEASES OF HUMAN CONCERN, INCLUDING MALARIA. THE VACCINE RESEARCH CENTER (VRC) HAS DEVELOPED TWO MONOCLONAL ANTIBODIES (M | $560K |
| Sep 17, 2025 | Department of Health and Human ServicesNIH NCI | 75N91019F00138 | 541715 | CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS | $2.5M |
| Sep 17, 2025 | Department of Health and Human ServicesNIH NCI | 75N91018F00057 | 561210 | IGF::OT::IGF ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODY (BNABS) DRUG SUBSTANCE (DS) CLINICAL TRIAL MATERIAL PRODUCTION AND RELEASE | $23K |
| Sep 17, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00007 | 541715 | FY25 TO-B | $2.1M |
| Sep 16, 2025 | Department of Health and Human ServicesNIH NCI | 75N91023F00023 | 541715 | CHARACTERIZATION OF NANOPARTICLES ENCAPSULATING OLIGONUCLEOTIDES FOR TARGETING ENDOCYTOSIS IN NOCICEPTORS FOR THE TREATMENT OF NEUROPATHIC PAIN | $361K |
| Sep 12, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00015 | 541715 | COORDINATED FACILITIES REQUIREMENTS FOR FY25 - FACILITIES TO I | $15.1M |
| Sep 12, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00021 | 541715 | MANUFACTURING CGMP GRADE HYDROXYCOBALAMINE | $62K |
| Sep 11, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00025 | 541715 | CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NES-100 AS A NASAL SPRAY OF A NEW ANALGESIC | $1.3M |
| Sep 11, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00019 | 541715 | LEAD OPTIMIZATION OF A LONG NON-CODING RNA (LNCRNA) AS A POTENTIAL LIPID- AND GLUCOSE-LOWERING THERAPEUTIC | $922K |
| Sep 11, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00023 | 541715 | STABILITY STUDY SUPPORT OF R-VK4-116 | $98K |
| Sep 10, 2025 | Department of Health and Human ServicesNIH NCI | 75N91021F00013 | 541715 | ENABLING NCI CLINICAL & RESEARCH DATA SHARING | $2.3M |
| Sep 10, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00018 | 541715 | MANUFACTURING PROCESS DEVELOPMENT OF 4-HB | $918K |
| Sep 10, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00020 | 541715 | PRODUCING USHER III RETINAL ORGANOIDS FROM PATIENT CELLS TO MEASURE THE EFFECT OF DRUG CANDIDATE | $795K |
| Sep 10, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00024 | 541715 | DEVELOP, QUALIFY IMMUNOLOGICAL ASSAYS, AND PROVIDE CLINICAL SAMPLE TESTING FOR AAV-BASED GENE THERAPY CLINICAL CANDIDATES | $2.5M |
| Sep 10, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00022 | 541715 | EVALUATION OF IVO COMPOUNDS IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS MODEL | $220K |
| Sep 5, 2025 | Department of Health and Human ServicesNIH NCI | HHSN26100052 | 561210 | IGF::OT::IGF B539 REFURBISHMENT&INFRASTRUCTURE UPGRADES TO B539/1ST FLOOR, PHASE 1 | $25K |
| Sep 5, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00010 | 541715 | IPP NCI FEDERALLY FUNDED RESEARCH AND DEVELOPMENT CENTER (FFRDC) CONTRACT TO-F | $2.5M |
| Sep 5, 2025 | Department of Health and Human ServicesNIH NCI | 75N91023F00020 | 541715 | STABLE CLONE PRODUCTION FOR ANTI-EBV MONOCLONAL ANTIBODIES | $2.1M |
| Sep 4, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00009 | 541715 | FY25 FACILITIES TO E - 126663 B539 MISC SAFETY UPGRADES | $1.7M |
| Aug 29, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00016 | 541715 | NCI OPERATIONAL TASK ORDER, FY26-FY27 | $55.9M |
| Aug 28, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00012 | 541715 | NIAID DCR FY26-27 OPERATIONAL TASK ORDER | $10.3M |
| Aug 28, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00013 | 541715 | THE NIAID DIR FY26-27 OPERATIONAL TASK ORDER | $1.3M |
| Aug 28, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00005 | 541715 | FY26 FFRDC LEASES | $27.8M |
| Aug 27, 2025 | Department of Health and Human ServicesNIH NCI | 75N91024F00027 | 541715 | FY24/FY25 FFRDC LEASES OPERATIONAL TASK ORDER | $490K |
Get Alerted Before Leidos Biomedical Research INC's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start Free